SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-053416
Filing Date
2020-04-29
Accepted
2020-04-29 16:31:04
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-2075_3defa14a.htm DEFA14A 32375
2 GRAPHIC g20753bgi001.gif GRAPHIC 109153
3 GRAPHIC g20753bgi002.gif GRAPHIC 176261
4 GRAPHIC g20753bgi003.gif GRAPHIC 51741
5 GRAPHIC g20753bgi004.gif GRAPHIC 5004
  Complete submission text file 0001104659-20-053416.txt   505091
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36306 | Film No.: 20830810
SIC: 2834 Pharmaceutical Preparations